You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epratuzumab

Showing 26 - 42 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Pediatric Cancer Trial in Houston (Epratuzumab, Fludarabine, Cyclophosphamide)

Terminated
Has Results
  • Leukemia
  • Pediatric Cancer
  • Epratuzumab
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
May 19, 2014

Systemic Lupus Erythematosus Trial in Worldwide (Epratuzumab)

Withdrawn
  • Systemic Lupus Erythematosus
  • Epratuzumab
  • Birmingham, Alabama
  • +53 more
May 20, 2014

Systemic Lupus Erythematosus Trial in Japan (Placebo, Epratuzumab 400 mg, Epratuzumab 1200 mg)

Completed
  • Systemic Lupus Erythematosus
  • Placebo
  • +4 more
  • Fukuoka, Japan
  • +6 more
Jan 16, 2014

Lymphoma Trial in Los Angeles (epratuzumab)

Unknown status
  • Lymphoma
  • epratuzumab
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013

Lymphoma Trial in Los Angeles (epratuzumab)

Unknown status
  • Lymphoma
  • epratuzumab
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Dec 18, 2013

Systemic Lupus Erythematosus Trial in United States (Epratuzumab)

Completed
  • Systemic Lupus Erythematosus
  • Epratuzumab
  • Birmingham, Alabama
  • +9 more
Jul 3, 2012

Systemic Lupus Erythematosus Trial in Worldwide (Epratuzumab)

Completed
  • Systemic Lupus Erythematosus
  • Epratuzumab
  • Birmingham, Alabama
  • +41 more
Jul 3, 2012

Lupus Erythematosus, Systemic Trial in New York, Pittsburgh, Charleston (epratuzumab)

Terminated
  • Lupus Erythematosus, Systemic
  • epratuzumab
  • New York, New York
  • +2 more
Mar 30, 2012

Systemic Lupus Erythematosus Trial in Worldwide (Epratuzumab, Placebo)

Terminated
  • Systemic Lupus Erythematosus
  • Epratuzumab
  • Placebo
  • Birmingham, Alabama
  • +59 more
Jun 6, 2012

Systemic Lupus Erythematosus Trial in Worldwide (epratuzumab)

Terminated
  • Systemic Lupus Erythematosus
  • epratuzumab
  • Birmingham, Alabama
  • +17 more
Nov 7, 2011

Systemic Lupus Erythematosus Trial in Worldwide (Epratuzumab, Placebo)

Completed
  • Systemic Lupus Erythematosus
  • Epratuzumab
  • Placebo
  • Birmingham, Alabama
  • +52 more
Sep 2, 2011

Leukemia, Lymphoma Trial in Belleville, Philadelphia (indium In 111 LL2 IgG, yttrium Y 90 epratuzumab)

Completed
  • Leukemia
  • Lymphoma
  • indium In 111 LL2 IgG
  • yttrium Y 90 epratuzumab
  • Belleville, New Jersey
  • +1 more
Jun 21, 2011

Lymphoma, Non-Hodgkin, Lymphomas: Non-Hodgkin, Lymphomas: Non-Hodgkin Cutaneous Lymphoma Trial in Stanford (Rituximab,

Completed
  • Lymphoma, Non-Hodgkin
  • +8 more
  • Stanford, California
    Stanford University School of Medicine
May 31, 2011

Leukemia, Lymphoma Trial in United States (biological, procedure, radiation)

Completed
  • Leukemia
  • Lymphoma
  • filgrastim
  • +4 more
  • Belleville, New Jersey
  • +3 more
Jun 21, 2011

Leukemia, Lymphoma Trial in Belleville (biological, drug, procedure, radiation)

Unknown status
  • Leukemia
  • Lymphoma
  • filgrastim
  • +8 more
  • Belleville, New Jersey
    Garden State Cancer Center
Jun 6, 2009

Systemic Lupus Erythematosus Trial run by the NIAMS (hLL2 (Epratuzumab))

Completed
  • Systemic Lupus Erythematosus
  • hLL2 (Epratuzumab)
  • Bethesda, Maryland
    National Institute of Arthritis and Musculoskeletal and Skin Dis
Mar 3, 2008

Non-Hodgkin's Lymphoma Trial (epratuzumab)

Completed
  • Non-Hodgkin's Lymphoma
  • epratuzumab
  • (no location specified)
Dec 20, 2007